Qaytona is free while it's in beta — Get started

Ingredients

Modified Citrus Pectin

MCP · Citrus pectin · Pectasol

Snapshot

IndicationsContraindications
  • Prostate-specific antigen doubling time1–3
  • Lead excretion4
  • Toxic metal excretion5
  • Fecal uranium excretion6
  • Pregnancy or nursing7
  • Diabetes or intestinal disorder7

Modified citrus pectin (MCP) is citrus pectin processed to a lower molecular weight, and it acts as a competitive antagonist of galectin-32. It is used for two things that follow from that profile.2 Men with biochemically relapsed prostate cancer after local therapy take it to lengthen prostate-specific antigen (PSA) doubling time1, 2, and people with metal exposure take it to increase excretion of lead, arsenic, and cadmium.

The prostate evidence comes from single-arm phase 2 studies that reported improved PSA doubling time without grade 3 or 4 toxicity2, 3. The metal data come from small pilot studies measuring excretion, and a placebo-controlled trial in knee osteoarthritis found no significant benefit over placebo. In obese rats with myocardial ischemia, a 2025 study found MCP reduced expression of fibrosis-related genes through galectin-3 inhibition; no human trial has tested it. Many products list modified citrus pectin, mostly as capsules and powders; see Form comparison.

United States product labels carry two kinds of caution: some say not to take it when pregnant or nursing7, and others direct people with diabetes or an intestinal disorder to consult a health care professional first7.

Last updated October 15, 2026. Read how we make monographs.

In the full monograph

33 sources, 20 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study.pubmed.ncbi.nlm.nih.govGuess, Scholz, Strum et al. · Prostate cancer and prostatic diseases · 2003 · Pubmed
  2. 2Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study.pubmed.ncbi.nlm.nih.govKeizman, Frenkel, Peer et al. · Nutrients · 2021 · Pubmed
  3. 3Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.pubmed.ncbi.nlm.nih.govKeizman, Frenkel, Peer et al. · Nutrients · 2023 · Pubmed
  4. 4The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels.pubmed.ncbi.nlm.nih.govZhao, Liang, Fan et al. · Alternative therapies in health and medicine · 2008 · Pubmed
  5. 5The effect of modified citrus pectin on urinary excretion of toxic elements.pubmed.ncbi.nlm.nih.govEliaz, Hotchkiss, Fishman et al. · Phytotherapy research : PTR · 2006 · Pubmed
  6. 6Modified Citrus Pectin / Alginate Dietary Supplement Increased Fecal Excretion of Uranium: A Family.pubmed.ncbi.nlm.nih.govEliaz, Weil, Schwarzbach et al. · Alternative therapies in health and medicine · 2019 · Pubmed
  7. 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm